한글목차

조류인플루엔자 백신 동향 및 전망

세계 조류인플루엔자 백신 시장은 2024년부터 2030년까지 8.7%의 CAGR을 기록하며 2030년까지 약 22억 달러 규모에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신뢰할 수 있고 효율적인 가금류 백신에 대한 수요 증가, 가금류 농장의 조류인플루엔자 발생 건수 증가, 조류인플루엔자에 대한 대중의 인식을 높이기 위한 정부의 적극적인 노력입니다. 닭, 오리, 거위, 칠면조, 칠면조, 메추라기 시장에서의 기회로 인해 세계 조류인플루엔자 백신 시장의 미래는 유망합니다.

• Lucintel의 예측에 따르면, 유형별로는 H5가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 용도별로는 닭고기가 가장 높은 성장이 예상됩니다.
• 지역별로는 APAC 지역이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

조류인플루엔자 백신 시장의 전략적 성장 기회

조류인플루엔자 백신 시장은 시장의 발전과 함께 많은 응용 분야가 전략적 역할을 할 것으로 예상됩니다. 시장 진입자들이 시장 역학을 활용하고 조류 독감으로 인해 발생할 수 있는 문제를 해결하기 위해서는 이러한 응용 분야에 대한 개념적 이해가 중요합니다. 따라서 이러한 기회를 파악하는 것은 기술 혁신과 종합적인 시장 대응력을 촉진하는 데 있어 매우 중요합니다.

• 상업용 가금류 : 상업용 가금류 산업은 여전히 가장 큰 성장 산업입니다. 생산성 향상과 바이오 보안 대책의 추진으로 양계를 위험에 빠뜨릴 수 있는 질병을 예방하고 안정적인 공급을 보장하기 위해 효율적인 백신 접종이 요구되고 있습니다.
• 뒤뜰 가금류 사육 : 뒤뜰 가금류 사육에 대한 관심이 높아짐에 따라 이 성장 부문이 백신 접종을 받을 수 있는 기회가 있습니다. 그러나 백신 접종에 대한 경제적 대안과 함께 좋은 교육적 노력은 이 뒷마당 가금류 사육 부문을 유지할 수 있습니다.
• 수출 시장 : 백신 제조 산업은 특히 가금류 산업이 성장하고 있는 신흥 경제국에서 주목할 만한 다양한 수출 시장을 가지고 있습니다. 현지 입지를 강화하고 국제적으로 요구되는 안전 표준을 준수함으로써 시장 점유율을 확대할 수 있습니다.
• 야생조류 보호에 대한 노력 : 야생조류 관리를 위한 관리 전략에 적절히 통합된 백신 프로그램은 가금류와 야생조류 사이의 생태적 균형과 생물 다양성 보존에 기여하여 유입을 줄임으로써 순수하게 기여할 수 있습니다.
• 연구 개발의 학술 협력 : 학술 기관과의 연구 개발 협력은 백신 기술의 혁신적인 솔루션을 제공하고 새로운 조류 독감 위협에 직면했을 때 능력을 극대화하는 데 도움이 될 수 있으므로 적극적으로 모색해야 합니다.

이러한 추세는 조류인플루엔자 백신 시장을 변화시키고 있으며, 모든 응용 분야에서 전략적 방향성이 필수적이라는 것을 보여줍니다. 이러한 성장 요인을 활용하면 양계업이 지속가능한 미래를 만들어 갈 수 있습니다.

조류독감백신 시장 활성화 요인 및 과제

조류인플루엔자 백신 시장에는 많은 원인과 촉진요인이 있으며, 직면하고 있는 과제에는 기술적, 경제적, 규제적 요인이 있습니다. 조류독감 위협에 대응하기 위한 백신 개발 및 배포 전략의 방향성을 형성합니다.

조류인플루엔자 백신 시장을 이끄는 요인은 다음과 같습니다.

• 가금류 생산의 성장 : 가금류 생산량 증가 : 세계 가금류 제품에 대한 수요가 증가함에 따라 효과적인 백신 생산량을 늘려야 할 필요성이 대두되고 있습니다. 이는 제조업체에 책임감을 부여하고 가금류의 건강을 보장하기 위해 제품 혁신과 발전을 향해 나아갈 수 있도록 유도합니다.
• 백신 개발의 발전 : 백신 개발의 발전에는 백신의 효율성과 생산성을 향상시키는 mRNA 기술 등이 포함되며, 이를 통해 더 나은 질병 관리와 효율적인 발병 통제를 유지할 수 있습니다.
• 정부의 참여와 투자 : 질병 예방과 국경 바이오 보안에 대한 정부의 노력과 투자가 백신 연구개발을 강화하고 이 시장을 활성화하고 있습니다.
• 바이오 보안에 대한 인식 증가 : 가금류 농가의 바이오 보안의 중요성에 대한 인식이 높아짐에 따라 더 건강한 가금류 군을 달성하기 위해 예방 백신 전략을 채택하여 경제적 손실을 줄일 수 있습니다.
• 국제 무역 요건 : 국제 무역의 엄격한 위생 규정은 광범위한 조류 백신 접종 프로그램을 요구하기 때문에 시장 요구 사항을 충족하는 조류인플루엔자에 대한 효과적인 백신이 필요합니다.

조류인플루엔자 백신 시장의 과제는 다음과 같습니다.

• 규제 장벽 : 규제 장벽 : 국내법의 복잡한 규제 체계로 인해 백신의 승인과 시장 진입이 지연되어 적절한 백신의 출시 시기가 지연될 수 있습니다.
• 경제적 제약 : 신흥 경제국에서는 경제적 제약으로 인해 백신을 구매할 수 없고 접근이 어려운 경우가 있습니다.
• 바이러스 균주의 진화 : 조류인플루엔자 바이러스의 끊임없는 변이는 백신의 효능을 복잡하게 만들고 있으며, 새로운 균주에 대한 지속적인 업데이트와 적응이 필요합니다.

목차

제1장 주요 요약

제2장 세계의 조류인플루엔자 백신 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 조류인플루엔자 백신 시장 동향(2018-2023년)과 예측(2024-2030년)
• 주 유형별 : 세계의 조류인플루엔자 백신 시장
  • H5
  • H9
  • H7
  • 기타
• 유형별 : 세계의 조류인플루엔자 백신 시장
  • 불활성화
  • 생약독화
  • 재조합
  • 벡터 기반
  • 기타
• 용도별 : 세계의 조류인플루엔자 백신 시장
  • 닭
  • 오리
  • 거위
  • 칠면조
  • 메추라기
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 조류인플루엔자 백신 시장
• 북미의 조류인플루엔자 백신 시장
• 유럽의 조류인플루엔자 백신 시장
• 아시아태평양의 조류인플루엔자 백신 시장
• 기타 지역의 조류인플루엔자 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 주식 유형별 세계의 조류인플루엔자 백신 시장 성장 기회
  • 유형별 세계의 조류인플루엔자 백신 시장 성장 기회
  • 용도별 세계의 조류인플루엔자 백신 시장 성장 기회
  • 지역별 세계의 조류인플루엔자 백신 시장 성장 기회
• 세계의 조류인플루엔자 백신 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 조류인플루엔자 백신 시장 생산능력 확대
  • 세계의 조류인플루엔자 백신 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Boehringer Ingelheim International
• Guangdong Wenshi Dahuanong Biotechnology
• Ceva
• Yebio Bioengineering
• Zoetis

영문목차

Avian Influenza Vaccine Trends and Forecast

The future of the global avian influenza vaccine market looks promising with opportunities in the chicken, duck, goose, turkey, and quail markets. The global avian influenza vaccine market is expected to reach an estimated $2.2 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are increasing need for reliable and efficient poultry vaccines, growing number of avian influenza outbreaks in poultry farms, and increased government efforts towards public awareness of avian flu.

• Lucintel forecasts that, within the type category, H5 is expected to witness the highest growth over the forecast period.
• Within the application category, chicken is expected to witness the highest growth.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Avian Influenza Vaccine Market

Avian Influenza Vaccine market trends are easy to identify. They are increasingly driven by technical improvements as well as shifts in the regulatory environment. Country and industry actions to control avian influenza lead naturally to the need to know these trends for the development and delivery of effective vaccines. Trends represent a collective effort to increase the effectiveness and availability of vaccines in a rapidly changing disease environment.

• More R&D: More investments in research and development are aiding in innovative formulations and delivery mechanisms for vaccines, which, apart from making it more potent against newer strains, enhance better global biosecurity.
• More recombinant vaccines: They would be an essential requirement for poultry health and the least disturbing element in food chains. It will ensure a local immunity level with fewer side effects.
• Improved Regulatory Environments: Tough regulations are forcing manufacturers to work on higher standards of safety. Consequently, vaccines produced are both safe for animals and humans while being simultaneously effective.
• International Cooperation Programs: Governments, research institutions, and private organizations worldwide collaborate with their international counterparts, thus making collaborations stronger. International partners share knowledge and resources to ensure that the best approach is used in dealing with avian influenza.

These trends remake the Avian Influenza Vaccine market through innovation and improved global cooperation for better poultry health and food security. Capitalizing on strategies in keeping with these trends can help address the complexities associated with avian influenza management.

Recent Developments in the Avian Influenza Vaccine Market

Recent work on Avian Influenza Vaccine supports new strategies aimed at augmenting the efficacy and distribution of vaccines step by step. These innovations are truly part of a continuous fight against avian flu since the poultry sector is up against the most pressing threats to its health and economic stability worldwide. Innovation and collaboration speak to the urgency to act against avian influenza since it is an ongoing threat.

• Next-Generation Vaccines: Vaccine platforms using mRNA technologies could revolutionize the management of avian influenza because they could be used for quicker vaccine production and are targeted toward developing an appropriate immune response.
• Supply Chain Strengthening: The initiative to strengthen vaccine supply chain mechanisms ensures the availability of vaccines in a timely manner during outbreaks. The supply chain and storage mechanisms are well-supported logistics and vaccine management solutions that would ensure the maintenance of the integrity of vaccines from production to administration.
• Integration of Digital Technologies: The use of digital technologies to track and monitor the effectiveness of vaccines. In turn, the processing of results may be done in real time, and the response efforts made effective.
• Public Awareness Campaigns: Increased benefit of vaccination to farmers through heightened awareness campaigns. This results in better health and productivity of flocks due to increased uptake rates.
• International Collaboration with Organizations: Strategic partnerships will enable knowledge exchange and resource sharing with organizations, such as the FAO, that positively impacts global strategies in fighting avian influenza.

These developments greatly influence the Avian Influenza Vaccine market by enhancing the effectiveness and accessibility of vaccine delivery, thus improving disease management and protecting the poultry industry worldwide. The market will be well-positioned for sustainable growth and resilience in any future outbreak if issues like these are confronted head-on.

Strategic Growth Opportunities for Avian Influenza Vaccine Market

A number of applications will be strategic for the Avian Influenza Vaccine market in this regard as the market evolves. A conceptual understanding of these applications is critical for market participants looking to capitalize on market dynamics and address the challenges likely to be generated by avian influenza. The identification of these opportunities is, therefore, of prime importance in fostering innovation and total market responsiveness.

• Commercial Poultry: In this category, the commercial poultry industry is still the largest growth industry. The drive for higher productivity and biosecurity measures demands efficient vaccination in preventing diseases that may jeopardize flocks and ensure a reliable supply.
• Backyard Poultry: With increased interest in backyard poultry farming, there is an opportunity for access to vaccination by this growing sector; although good educational initiatives with economic options for vaccination may sustain this sector of backyard poultry farmers.
• Export Markets: The vaccine manufacturing industry has various notable export markets, especially in the emerging economies with growing poultry industries. The on-site presence can be increased there, and with increased observance of internationally required safety standards, market share might increase.
• Wild Bird Conservation Efforts: Properly assimilated into the control strategies for wildlife management, vaccine programs can genuinely help conserve the ecological balance and biodiversity between domestic and wild birds by reducing transfers.
• Academic Collaborations in Research and Development: Research and development collaborations with academic institutions should be sought actively, as they will result in innovative solutions for vaccine technologies and help maximize capabilities in the face of emerging avian influenza threats.

These trends are transforming the Avian Influenza Vaccine market and indicate that strategic direction is a must in all the applications, thus helping poultry health systems to be strong in their designs. Taking advantage of these growth factors would make it feasible to shape a future where poultry farming could be sustainable.

Avian Influenza Vaccine Market Driver and Challenges

There are many causes or drivers of the Avian Influenza Vaccine Market, and the challenges facing it include several technological, economic, and regulatory types. Understanding these dynamics is important for stakeholders navigating this landscape; they shape the direction of vaccine development and deployment strategies in response to avian influenza threats.

The factors responsible for driving the avian influenza vaccine market include:

• Growth in Poultry Production: Growing demand for poultry products worldwide creates the necessity of increasing the production of effective vaccination. This adds a sense of responsibility to manufacturers and directs them toward innovating and advancing their products to ensure the health of their flocks.
• Advancements in Vaccine Development: Advances in the development of vaccines encompass mRNA technology, among others, to increase the efficiency and productivity of vaccines, thereby maintaining better disease management and efficient control of outbreaks.
• Government Involvement and Investments: Government initiatives and investments in disease prevention and border biosecurity enhance research and development of vaccines, thus fueling this market.
• Growing Biosecurity Awareness: Increasing awareness among poultry farmers about the importance of biosecurity boosts the adoption of preventive vaccination strategies to achieve healthier flocks and therefore reduce economic losses.
• International Trade Requirements: Strict health regulations in international trade require a broad avian vaccination program, thus necessitating effective vaccines against avian influenza that meet market requirements.

Challenges in the avian influenza vaccine market include:

• Regulatory Barriers: The complexity of the regulatory regime within national legislation delays vaccine approvals and entry into the market, whereby the timing of the availability of appropriate vaccines can be impeded.
• Economic Limitations: In some developing economies, due to economic constraints, vaccines would be unaffordable and inaccessible; thus, large-scale vaccination programs would be affected.
• Evolution in Virus Strains: Continuous mutation in avian influenza viruses complicates the effectiveness of vaccines, necessitating constant updates and adaptations against newly reappearing strains.

The drivers and challenges powerfully impact the Avian Influenza Vaccine market, shaping some of the innovation strategies and confronting global concerns over poultry health. Only by understanding and responding to these factors will stakeholders in this crucial market navigate the complexities in this area. The ability to adapt to this dynamic will be crucial for long-term sustainability and effectiveness in managing avian influenza.

List of Avian Influenza Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies avian influenza vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the avian influenza vaccine companies profiled in this report include-

• Boehringer Ingelheim International
• Guangdong Wenshi Dahuanong Biotechnology
• Ceva
• Yebio Bioengineering
• Zoetis

Avian Influenza Vaccine by Segment

The study includes a forecast for the global avian influenza vaccine by strain type, type, application, and region.

Avian Influenza Vaccine Market by Strain Type [Analysis by Value from 2018 to 2030]:

• H5
• H9
• H7
• Others

Avian Influenza Vaccine Market by Type [Analysis by Value from 2018 to 2030]:

• Inactivated
• Live Attenuated
• Recombinant
• Vector-Based
• Others

Avian Influenza Vaccine Market by Application [Analysis by Value from 2018 to 2030]:

• Chicken
• Duck
• Goose
• Turkey
• Quail
• Others

Avian Influenza Vaccine Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Avian Influenza Vaccine Market

Advancements in the Avian Influenza Vaccine market are witnessing significant progress across all geographies, driven by outbreaks and the powerful need to improve biosecurity. However, the avian influenza threats loom large ahead for poultry health and the world's food supply, and a host of countries, including the U.S., China, Germany, India, and Japan, are working together to advance vaccine efficacy, streamline channels of distribution, and develop comprehensive surveillance networks. These initiatives don't only connect directly to immediate health issues but also contribute to long-term strategies for tackling avian flu outbreaks in different parts of the world.

• United States: The U.S. has increased its investment in vaccine research and joined forces with biotech companies to improve response mechanisms. Recently, approvals have been granted to new vaccine strains that promise better protection against rising H5N1 variants and enhanced biosecurity in poultry farms.
• China: Governmental innovation has allowed the vaccine market to flourish in China with new vaccines. Now, China is shifting focus toward recombinant vaccines that demonstrate efficiency and safety for effective production and cater to both domestic and international exports.
• Germany: With all the investments Germany has made through public-private partnerships into high-performance vaccines, new formulation and delivery technologies are awaited to enhance the immune response, particularly for commercial poultry sectors, which are likely to enhance food security and exports.
• India: Vaccination in India has gradually increased since the growth of the country's poultry industry. The government encourages local vaccine manufacturers to design cost-effective vaccines, and as a result, accessibility has increased, and biosecurity measures have strengthened against outbreaks of avian influenza.
• Japan: With the new developments in vaccine technology, Japan is engaging in international collaborations with research institutions. Among these are newly developed inactivated as well as live-attenuated vaccines that can protect both wild and domestic birds, thus addressing ecological and economic concerns.

Features of the Global Avian Influenza Vaccine Market

Market Size Estimates: Avian influenza vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Avian influenza vaccine market size by strain type, type, application, and region in terms of value ($B).

Regional Analysis: Avian influenza vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different strain types, types, applications, and regions for the avian influenza vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the avian influenza vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the avian influenza vaccine market by strain type (H5, H9, H7, and others), type (inactivated, live attenuated, recombinant, vector-based, and others), application (chicken, duck, goose, turkey, quail, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Avian Influenza Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Avian Influenza Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Avian Influenza Vaccine Market by Strain Type
  • 3.3.1: H5
  • 3.3.2: H9
  • 3.3.3: H7
  • 3.3.4: Others
• 3.4: Global Avian Influenza Vaccine Market by Type
  • 3.4.1: Inactivated
  • 3.4.2: Live Attenuated
  • 3.4.3: Recombinant
  • 3.4.4: Vector-Based
  • 3.4.5: Others
• 3.5: Global Avian Influenza Vaccine Market by Application
  • 3.5.1: Chicken
  • 3.5.2: Duck
  • 3.5.3: Goose
  • 3.5.4: Turkey
  • 3.5.5: Quail
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Avian Influenza Vaccine Market by Region
• 4.2: North American Avian Influenza Vaccine Market
  • 4.2.1: North American Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.2.2: North American Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.3: European Avian Influenza Vaccine Market
  • 4.3.1: European Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.3.2: European Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.4: APAC Avian Influenza Vaccine Market
  • 4.4.1: APAC Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.4.2: APAC Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.5: ROW Avian Influenza Vaccine Market
  • 4.5.1: ROW Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.5.2: ROW Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Avian Influenza Vaccine Market by Strain Type
  • 6.1.2: Growth Opportunities for the Global Avian Influenza Vaccine Market by Type
  • 6.1.3: Growth Opportunities for the Global Avian Influenza Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Avian Influenza Vaccine Market by Region
• 6.2: Emerging Trends in the Global Avian Influenza Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Avian Influenza Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Avian Influenza Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boehringer Ingelheim International
• 7.2: Guangdong Wenshi Dahuanong Biotechnology
• 7.3: Ceva
• 7.4: Yebio Bioengineering
• 7.5: Zoetis